Restricted content. Do you want to read more?
A Swiss CBD company claims to have become the first cannabidiol firm to use liposomes to deliver the substance into users’ bodies.
Cibdol, based in Liestal, near Basel, says its range of products, launched in December, will enter the user’s system as much as four times quicker than traditional oils and capsules.
Because they are made from a substance extensively found in cells – phospholipids – they penetrate directly into tissue and cell walls, and can pass directly into a patient’s bloodstream....